Executive Team
David A Young - President and Chief Executive Officer
David Young has over 25 years of experience in medical and hospital real estate, monetizing in excess of $1.5B of healthcare real estate during his career. Mr. Young has extensive public capital markets experience working with several companies from inception through public offering. He has worked in all facets of the public markets and has both institutional and mergers and acquisitions expertise.He has served as CEO and Founder of Global Medical REIT Inc. (NYSE: GMRE) and as Founder and Senior Vice President of Acquisitions at Windrose Medical Properties Trust (NYSE: WRS), which was later acquired by Welltower (NYSE: WELL). Mr. Young was the corporate officer responsible for business development at Healthcare Property Investors from startup through year 10 (NYSE: HCP), growing AUM from $300M to over $3.5B. Mr. Young previously developed a specialized medical real estate financing function at GE Capital. His earlier experiences include Director of Business Development at American Hospital Supply Corp., Vice President of Corporate Marketing at Hospital Corporation of America (“HCA”), and Assistant Hospital Director at Vanderbilt University Medical Center.
Frank Wilch - SVP - Business Development (Eastern Region)
Frank Wilich is an experienced senior healthcare executive with proven success in medical facility real estate finance. Mr. Wilich has developed and managed critical care hospitals. In 2001, he co-founded Specialty Hospitals of America, a $300M private integrated hospital and long-term care system. He served as the company’s Chief Development Officer from 2001 until 2012, and then President through sale in 2014. Mr. Wilich’s career also includes: Territory Manager for IBM Corp., various roles including Director of Marketing for American Hospital Supply Corp,,  CEO & Co-Founder of Pharmco Products, a medical products business from inception to ultimate sale with $60M in revenue. Additionally, Mr. Wilich was President and Treasurer at Polychem Corporation, a medical technology manufacturing company in long term care, that expanded through internal growth and was sold in 1998. Mr. Wilich remains active on the Board of Directors of a CT-based medical technology company in the surgical visualization space.
Mark Kennedy - SVP - Business Development (Western Region)
Mark Kennedy has originated $50M in medical real estate assets during his recent medical real estate business development res ponsibilities, resulting in net operating property income of $5M. Mr. Kennedy possesses significant healthcare executive experience, including being Chief Development Officer and CEO of a company focused on developing physician hospital joint ventures. He was also Chief Operating Officer for a $120M healthcare contract services company and VP of Development for a national hospital contract management company in which he was responsible for in excess of $225M in managed revenues. Furthermore, Mr. Kennedy was Senior Vice President of one of the largest U.S. for- profit hospital management companies.
Conn Flanigan – Secretary and General Counsel
Conn Flanigan has over 20 years legal experience advising companies as in-house counsel. From 2013 to 2017, he served as Secretary and General Counsel for Global Medical REIT, Inc. (NYSE:GMRE) advising Global Medical REIT from its startup, through 18 acquisitions of healthcare facilities worth more than $250 million, and through its IPO on the NYSE in 2016. His primary practice areas are corporate law, real estate acquisitions and financing, public company governance and compliance, and 1934 Act disclosures. Mr. Flanigan has also served as corporate counsel for several US subsidiaries of Singapore eDevelopment, Ltd. and also with US subsidiaries of Zensun International Holdings Limited (formerly known as Heng Fai Enterprises Limited; HKSE:185).
Moe Chan - Director Corporate Development
Moe Chan has a wealth of experience focused on the real estate industry. He served as the Group Chief Development Officer and Executive Director of Singapore Exchange-listed Singapore eDevelopment Limited and was responsible for the Group’s international property development business. Prior to that he was the Group Chief Operating Officer of Zensun International Holdings Limited (formerly known as Heng Fai Enterprises Limited; HKSE:185) responsible for the company’s global business operations consisting of REIT ownership and management, property development, hotels and hospitality, as well as property and securities investment and trading. Earlier in his career he was Executive Director and Chief of Project Development of Singapore Exchange-listed SingHaiyi Group Ltd, overseeing all of its property development projects.

In addition to real estate he has a diverse background in the fields of hospitality, investment, technology and consumer finance. He holds a Master’s Degree in Business Administration with honours from the University of Western Ontario, a Master’s Degree in Electro-Mechanical Engineering with honours and a Bachelor’s Degree in Applied Science with honours from the University of British Columbia.
Gabriela Gheorghe – VP Acquisitions
Gabriela has an extensive background in healthcare finance which includes successful and progressive performance in leading key business processes and providing analytical tools necessary to drive growth and operational efficiencies. She worked in corporate actions for Deutsche Bank and in finance and business intelligence for major healthcare companies like HCA - Hospital Corporation of America, IASIS Healthcare and Steward Healthcare System. She conducted numerous market analyses and coordinated several acquisitions by leading deal-related analysis including financial modeling, benchmarking, due diligence and deal structuring. Gabriela has a double major in economics and statistics with a minor in information technology. She has graduate degrees in business administration and healthcare management from Belmont and Vanderbilt University.